Peijia Medical Limited (HKG:9996)
Hong Kong · Delayed Price · Currency is HKD 4.975
-0.085 (-1.68%)
Aug 21, 2026, 4:08 PM HKT
Peijia Medical Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 783.99 | 712.87 | 615.48 | 441.13 | 250.83 | 136.53 | |
Revenue Growth | 17.42% | 15.82% | 39.52% | 75.86% | 83.71% | 253.21% |
Cost of Revenue | 255.53 | 226.82 | 181.86 | 115.76 | 74.63 | 40.88 |
Gross Profit | 528.47 | 486.05 | 433.62 | 325.37 | 176.2 | 95.65 |
Selling, General & Admin | 410.2 | 446.83 | 479.44 | 466.62 | 365.06 | 207.68 |
Research & Development | 227.13 | 254.36 | 203.42 | 205.5 | 147.02 | 131.3 |
Other Operating Expenses | 10.04 | -19 | -19.54 | -19.72 | -12.76 | -7.46 |
Operating Expenses | 647.37 | 682.19 | 663.32 | 652.4 | 499.32 | 331.52 |
Operating Income | -118.9 | -196.14 | -229.7 | -327.03 | -323.12 | -235.87 |
Interest Expense | -14.86 | -11.73 | -4.74 | -0.18 | -2.32 | -0.19 |
Interest & Investment Income | 7.81 | 7.81 | 22.48 | 39.44 | 46.63 | 24.77 |
Earnings From Equity Investments | - | - | - | - | -0.17 | - |
Currency Exchange Gain (Loss) | -12.05 | -12.05 | 5.7 | -17.78 | 106.42 | -48.14 |
Other Non Operating Income (Expenses) | -4.38 | - | - | -1.58 | 0.27 | - |
EBT Excluding Unusual Items | -142.38 | -212.11 | -206.25 | -307.13 | -172.28 | -259.42 |
Gain (Loss) on Sale of Investments | 9.46 | 9.46 | -14.98 | 3.77 | 0.58 | - |
Gain (Loss) on Sale of Assets | 0.05 | 0.05 | -0.37 | -0.22 | -0.03 | -0.22 |
Other Unusual Items | - | - | - | -87.92 | -226.51 | -314.58 |
Pretax Income | -132.87 | -202.6 | -221.6 | -391.5 | -398.24 | -574.22 |
Income Tax Expense | 13.13 | 5.59 | 6.89 | 1.05 | 9.57 | - |
Earnings From Continuing Operations | -146 | -208.18 | -228.49 | -392.55 | -407.81 | -574.22 |
Minority Interest in Earnings | 5 | 4.9 | 1.92 | 0.03 | - | - |
Net Income | -140.99 | -203.29 | -226.58 | -392.53 | -407.81 | -574.22 |
Net Income to Common | -140.99 | -203.29 | -226.58 | -392.53 | -407.81 | -574.22 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 695 | 665 | 669 | 679 | 673 | 662 |
Shares Outstanding (Diluted) | 695 | 665 | 669 | 679 | 673 | 662 |
Shares Change | 4.88% | -0.64% | -1.44% | 0.91% | 1.74% | 41.68% |
EPS (Basic) | -0.20 | -0.31 | -0.34 | -0.58 | -0.61 | -0.87 |
EPS (Diluted) | -0.20 | -0.31 | -0.34 | -0.58 | -0.61 | -0.87 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | - | -252.48 | -254.32 | -806.54 | -506.61 | -506.11 |
Free Cash Flow Per Share | - | -0.38 | -0.38 | -1.19 | -0.75 | -0.77 |
Gross Margin | 67.41% | 68.18% | 70.45% | 73.76% | 70.25% | 70.06% |
Operating Margin | -15.17% | -27.51% | -37.32% | -74.13% | -128.82% | -172.75% |
Profit Margin | -17.98% | -28.52% | -36.81% | -88.98% | -162.58% | -420.57% |
Free Cash Flow Margin | - | -35.42% | -41.32% | -182.84% | -201.97% | -370.68% |
EBITDA | -57.13 | -134.36 | -176.77 | -290.07 | -292.57 | -212.61 |
EBITDA Margin | -7.29% | -18.85% | -28.72% | -65.76% | -116.64% | -155.72% |
D&A For EBITDA | 61.78 | 61.78 | 52.93 | 36.96 | 30.54 | 23.26 |
EBIT | -118.9 | -196.14 | -229.7 | -327.03 | -323.12 | -235.87 |
EBIT Margin | -15.17% | -27.51% | -37.32% | -74.13% | -128.82% | -172.75% |
Advertising Expenses | - | 83.88 | 77.41 | 67.53 | 48.12 | 14.99 |